| Product NDC: | 65162-687 |
| Proprietary Name: | Lorazepam |
| Non Proprietary Name: | Lorazepam |
| Active Ingredient(s): | 2 mg/mL & nbsp; Lorazepam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65162-687 |
| Labeler Name: | Amneal Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091383 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100201 |
| Package NDC: | 65162-687-84 |
| Package Description: | 30 mL in 1 BOTTLE, DROPPER (65162-687-84) |
| NDC Code | 65162-687-84 |
| Proprietary Name | Lorazepam |
| Package Description | 30 mL in 1 BOTTLE, DROPPER (65162-687-84) |
| Product NDC | 65162-687 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lorazepam |
| Dosage Form Name | CONCENTRATE |
| Route Name | ORAL |
| Start Marketing Date | 20100201 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals, LLC |
| Substance Name | LORAZEPAM |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |